stockrowAnika Therapeutics Inc. (ANIK) vs Emergent Biosolutions Inc. (EBS)
- Anika Therapeutics Inc. ANIK 19.31 −5.34%
- Emergent Biosolutions Inc. EBS 5.92 +0.34%
Anika Therapeutics Inc. and Emergent Biosolutions Inc. are both Drug Manufacturers Specialty & Generic companies. Emergent Biosolutions Inc. is the larger, with a market value of $300.8M against $258.7M — 1.2× the size. Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −17.7%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −40.2%) and the higher return on invested capital (−3.24% vs −17.5%). Across the 20 metrics below, Anika Therapeutics Inc. leads on 11 and Emergent Biosolutions Inc. on 9.
Valuation
Profitability
| Metric | ANIK | EBS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 62.16% | 48.42% | 53.51% |
| Operating margin | (4.24%) | (27.70%) | 0.00% |
| Net margin | (3.14%) | (40.16%) | (2.45%) |
| Free cash flow margin | 0.47% | 29.89% | 0.00% |
| Return on equity | (2.66%) | (58.21%) | (0.80%) |
| Return on assets | (2.04%) | (21.23%) | (1.67%) |
| Return on invested capital | (3.24%) | (17.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack